Fundraising FoxFormation Venture Engineering
Venture studioBoston · Pre-Seed · 19 people tracked
Find your way into Formation Venture Engineering
Each arrow is one introduction. Sign up to fill in the first one.
Ask Anisha Gupta to introduce you to Rahul Bhansali
You →Anisha · together at Re Nuble →Rahul
Ask Jamie Chen to introduce you to Amanda Zimmerman
You →Jamie · together at Axonis Therapeutics →Amanda
Ask Sam Okafor to introduce you to Gary Magnant
You →Sam · together at SAGE SCIENCE, INC. →Gary
Sign up to find every way you can get introduced to Formation Venture Engineering
- Your email: who you already know at Formation Venture Engineering, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Formation Venture Engineering team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Formation Venture Engineering argues that traditional investing misaligns the incentives of scientists, founders, and LPs. It partners with leading institutions and companies to source proven, high-impact IP with large untapped commercial potential, and cross-pollinates IP across disciplines to unlock new commercial use cases. The firm actively co-founds companies around this IP alongside scientific cofounders, running a rigorous 'Venture Engineering' process to systematically de-risk both the technology and the commercial opportunity. Operating as a venture holdco, it is designed to reach fast, high-quality exits that produce equitable outcomes for all stakeholders.
Source: firm website, verified Aug 16, 2026.
Team · 19 people
from the firm's website & public directories
Founder mafia
4 people who came through Formation Venture Engineering went on to found or lead other companies.
What they invest in
from 8 of 11 portfolio companiesBiotech ×7Healthtech ×4Medical Devices ×4AI & Machine Learning ×2Deep Tech ×2Digital Health ×1Hardware ×1
HQs:United States×6
Investments · 11 tracked
founders shown can be your intro pathBy year:2022 · 22021 · 12020 · 14 dated
Adeptrix develops the exoBAMS platform, using antibody-based immunoaffinity capture of extracellular vesicles combined with MALDI mass spectrometry to profile proteins, lipids, metabolites and other molecules from a single blood sample.
AI & Machine LearningBiotechMedical Devices
Vladislav Bergo(Founder)in
Akston Biosciences develops protein-based therapies for pets to support veterinary care and improve treatment accessibility.
BiotechHealthtechBeverly, US
Todd C. Zion(Executive Officer, Director)inJames Herriman(Executive Officer)Robyn Davis(Director)Lovick E. Cannon(Director)Thomas M. Lancaster(Executive Officer, Director)
Co-investorsBoston Harbor Angels
LeviSense Medical is a Massachusetts-based medical device company developing next-generation technology for therapeutic beds used in wound care.
HardwareHealthtechMedical DevicesBeverly, US
Dave Bertoni(COO & Co-Founder)inShri Parikh(CEO & Director)inMichael McGarrity(Director)Peter Rock(Chief Financial Officer)inDonald Dye(Director)
BoardRahul Bhansali(Director)in
Co-investorsICV Venture Engineering
NeuroDex develops blood-based biomarkers and diagnostic assays for neurological diseases, including rare genetic disorders, Parkinson's disease, Alzheimer's disease, and ALS.
BiotechDigital HealthMedical DevicesArlington, US
Erez Eitan(Executive Officer, Director)inRaphael Nir(Director)Oded Biran(Executive Officer, Director)
Co-investorsICVICV Venture Engineering
NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
AI & Machine LearningBiotechDeep TechHealthtechActon, US
Ruchi Chauhan(Director)
Co-investorsIllumina Accelerator
Twilight develops injectable precision immunotherapies to train the body's immune system to treat chronic diseases at scale.
BiotechDeep TechHealthtechMedical Devices
Ajay Verma(CEO, Co-Founder)Rahul Bhansali(CBO, Co-Founder)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Oligo FoundryTribioticaTwilightVakston
Frequently asked questions
- How many investments has Formation Venture Engineering made?
- Formation Venture Engineering has 11 tracked investments.
- What stage does Formation Venture Engineering invest at?
- Formation Venture Engineering invests at the Pre-Seed stage.
- What sectors does Formation Venture Engineering focus on?
- Formation Venture Engineering focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is Formation Venture Engineering located?
- Formation Venture Engineering is headquartered in Boston.
Media · Podcasts & interviews
featuring the teamFormation Venture Engineering Presentation by Rahul Bhansali, FreeMind Elite
FreeMind Group · Rahul Bhansali
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
BOLD Capital Partners is a venture capital firm that backs entrepreneurs and companies pursuing transformative science and technology aimed at disrupting and democratizing large markets and addressing major human challenges.